KWS BioTest Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 44


  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $25.3M

KWS BioTest General Information


Operator of a contract research organization intended to offer in-vitro and in-vivo discovery testing services for immuno-oncology and inflammatory and infectious diseases. The company offers drug discovery services, models of inflammatory and autoimmune diseases, vaccine studies, and models of infection and cancer models, thereby enabling development companies to get additional tools in the active therapeutic research areas of oncology and immunology.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Robinson Building Chesterford Park
  • Little Chesterford, Saffron Walden
  • Bristol CB10 1XL
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KWS BioTest Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 11-Jan-2018 $25.3M 000.00 Completed Generating Revenue
2. Seed Round Completed Generating Revenue
1. Spin-Off 01-Dec-2003 Completed Startup
To view KWS BioTest’s complete valuation and funding history, request access »

KWS BioTest Comparisons

HQ Location
Total Raised
Post Valuation
Operator of a contract research organization intended to offer in-vitro and in-vivo discovery testing services for immun
Laboratory Services (Healthcare)
Bristol, United Kingdom
44 As of 2017
000.00 0000-00-00


ed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad min
Louisville, CO
000 As of 0000
000000000 00000


t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
Minneapolis, MN
000 As of 0000
00000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

KWS BioTest Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biodesix Formerly VC-backed Louisville, CO 000 00000 000000000 00000
Advanced Cell Diagnostics Formerly VC-backed Minneapolis, MN 000 000.00 000000&0 000.00
Fate Therapeutics Formerly VC-backed San Diego, CA 000 00000 00000000 00000
Saniona Corporation Glostrup, Denmark 00 000.00 000000 - 000 000.00
Crown Bioscience Formerly VC-backed San Diego, CA 000 00000 000000&0 00000
You’re viewing 5 of 12 competitors. Get the full list »

KWS BioTest Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KWS BioTest Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Wyvern Fund Venture Capital Minority 000 0000 000000 0
To view KWS BioTest’s complete investors history, request access »

KWS BioTest FAQs

  • When was KWS BioTest founded?

    KWS BioTest was founded in 2003.

  • Who is the founder of KWS BioTest?

    Neil Williams Ph.D is the founder of KWS BioTest.

  • Where is KWS BioTest headquartered?

    KWS BioTest is headquartered in Bristol, United Kingdom.

  • What is the size of KWS BioTest?

    KWS BioTest has 44 total employees.

  • What industry is KWS BioTest in?

    KWS BioTest’s primary industry is Laboratory Services (Healthcare).

  • Is KWS BioTest a private or public company?

    KWS BioTest is a Private company.

  • What is the current valuation of KWS BioTest?

    The current valuation of KWS BioTest is 000.00.

  • What is KWS BioTest’s current revenue?

    The current revenue for KWS BioTest is 000000.

  • Who are KWS BioTest’s investors?

    Wyvern Fund has invested in KWS BioTest.

  • Who are KWS BioTest’s competitors?

    Biodesix, Advanced Cell Diagnostics, Fate Therapeutics, Saniona, and Crown Bioscience are some of the 12 competitors of KWS BioTest.

  • When was KWS BioTest acquired?

    KWS BioTest was acquired on 11-Jan-2018.

  • Who acquired KWS BioTest?

    KWS BioTest was acquired by Charles River Laboratories International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »